DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for DBV Technologies S.A. (DBVT)
« Back to company indexDBVT Chatter Timeline
Stock Ticker for DBVT
Most Active Tweeters for DBVT
| User | Tweets |
|---|---|
| @Sports_bios | 3 |
| @Gambiste1 | 2 |
| @AlertTrade | 2 |
| @JonathanWexler3 | 1 |
| @biofeed | 1 |
Recent Tweets for DBVT
 |
@TheMarketsDaily DBV TECHNOLOGIE/S $DBVT Sees Unusually-High Trading Volume https://t.co/shilwjXM7n September 13th 2019, 11:09pm |
 |
@bal221 @JonathanWexler3 $DBVT - Having a less potent and safer desensitizing patch on the market that may not require such… https://t.co/mAEqLZcJgL September 13th 2019, 10:09pm |
 |
@JonathanWexler3 $DBVT - the entire argument for their singular trial being sufficient for approval was that they’re safe. They miss… https://t.co/pq4huRazg6 September 13th 2019, 7:09pm |
 |
@Gambiste1 RT @YaChristle: @fierro7676 hi I like $aimt and $dbvt September 13th 2019, 6:09pm |
 |
@YaChristle @fierro7676 hi I like $aimt and $dbvt September 13th 2019, 6:09pm |
 |
@BertrandBio What I was writing about $DBVT vs $AIMT 3.5y ago after the AAAAI meeting... Things can revert rapidly. 1.5y later… https://t.co/D2B8N6IR5T September 13th 2019, 5:09pm |
 |
@AlertTrade SOCIAL ACTIVITY: $DBVT - DBV Technologies SA American ? TradeIdeas via ? https://t.co/VS8RO1bzXJ September 13th 2019, 4:09pm |
 |
@BTLipschultz Using shares of $DBVT as a proxy of how the $aimt panel is going? ADRs rose as much as 7.8% (still within its recen… https://t.co/LTrGDcv1iI September 13th 2019, 1:09pm |
 |
@hiddensmallcaps $AIMT halted pending decision review by FDA. No position but this and $DBVT are playing in a potentially enormous m… https://t.co/XavK7MqHRE September 13th 2019, 11:09am |
 |
@Sports_bios @WilliamGerber1 You are right on the mark - $DBVT doesn;t have the data on such population.. knowing the landscape… https://t.co/WLyutcIOL8 September 12th 2019, 6:09am |
|
@Gambiste1 RT @biofeed: $DBVT tmrw September 12th 2019, 12:09am |
 |
@biofeed $DBVT tmrw September 11th 2019, 10:09pm |
 |
@WilliamGerber1 @Sports_bios Unfortunately $DBVT went a different direction - their P3 trial treated patients with higher threshold… https://t.co/cNzbL1svJ9 September 11th 2019, 8:09pm |
|
@Sports_bios With $DBVT patches, they need to have patients to get some sort of sensitivity test regularly.. Me in the camp of t… https://t.co/8So3osYcxI September 11th 2019, 6:09pm |
|
@Sports_bios After $AIMT - $DBVT is next - will FDA accept the BLA?? That;s the big Q.. Assume it does, the role the patches p… https://t.co/m3zf3i3a6Z September 11th 2019, 6:09pm |
|
@AlertTrade RT @theflynews: Aimmune jumps as FDA materials seen as good sign for peanut allergy treatment $AIMT $DBVT https://t.co/YP1qlXxxcs https://t… September 11th 2019, 12:09pm |
 |
@theflynews Aimmune jumps as FDA materials seen as good sign for peanut allergy treatment $AIMT $DBVT https://t.co/YP1qlXxxcs https://t.co/IMFps9HYxw September 11th 2019, 12:09pm |
 |
@TickerReport Brokerages Expect DBV TECHNOLOGIE/S $DBVT to Announce -$0.52 Earnings Per Share https://t.co/5y0yo7cZ6T September 9th 2019, 1:09pm |
|
@TickerReport DBV TECHNOLOGIE/S $DBVT Cut to “Sell” at BidaskClub https://t.co/1HnAF8vnr6 August 11th 2019, 5:08am |
 |
@registrarjourn DBV TECHNOLOGIE/S $DBVT Cut to “Hold” at Zacks Investment Research https://t.co/yVOrrNOHOs August 10th 2019, 6:08pm |
 |
@EnterpriseLeade DBV TECHNOLOGIE/S $DBVT Cut to “Hold” at Zacks Investment Research https://t.co/LIupeub3aa August 10th 2019, 6:08pm |
 |
@dispatchtribune DBV TECHNOLOGIE/S $DBVT Cut to “Hold” at Zacks Investment Research https://t.co/mw3oapT4YE August 10th 2019, 6:08pm |
 |
@ZolmaxNews DBV TECHNOLOGIE/S $DBVT Downgraded by BidaskClub https://t.co/wqnB4vJnTC August 10th 2019, 2:08pm |
 |
@ThisLincolnian DBV TECHNOLOGIE/S $DBVT Downgraded by BidaskClub https://t.co/RwZCMZuW0N August 10th 2019, 2:08pm |
 |
@WatchlistN DBV TECHNOLOGIE/S $DBVT Sees Unusually-High Trading Volume https://t.co/LBh9qfSREI August 10th 2019, 2:08pm |
 |
@dakotafinancial DBV TECHNOLOGIE/S $DBVT Downgraded by Zacks Investment Research https://t.co/XMihJVAPZs August 9th 2019, 5:08pm |
 |
@MLTherapeutics @DBVTechnologies $DBVT Submits BLA to U.S. FDA for Viaskin Peanut for the Treatment of #peanutallergy https://t.co/GZNA0pUvFf August 9th 2019, 12:08am |
 |
@stocknewstimes DBV TECHNOLOGIE/S $DBVT Sees Unusually-High Trading Volume https://t.co/tQl60D2DMs August 8th 2019, 11:08pm |
 |
@macondailynews DBV TECHNOLOGIE/S $DBVT Sees Unusually-High Trading Volume https://t.co/JB68TE7vqm August 8th 2019, 11:08pm |
 |
@AjTrader7 RT @4topstocks: Traded $DBVT today which was gapping up 1.50 on FDA application news. So what? In my mind I heard AJ scream SHORT. Lol. Gl… August 8th 2019, 5:08pm |
 |
@4topstocks Traded $DBVT today which was gapping up 1.50 on FDA application news. So what? In my mind I heard AJ scream SHORT.… https://t.co/LJqFhyN7Ek August 8th 2019, 5:08pm |
|
@dakotafinancial DBV TECHNOLOGIE/S $DBVT Downgraded by BidaskClub to “Sell” https://t.co/MHNcdOTo4N August 8th 2019, 1:08pm |
 |
@ProVesting $DBVT: DBV Resubmits Regulatory Application For Peanut Allergy Drug …: https://t.co/oBujXp9Bzg August 8th 2019, 10:08am |
|
@ProVesting $DBVT $HEXO: 25 Healthcare Stocks Moving In Today’s Pre-Market Session: https://t.co/ADE3n59qpu August 8th 2019, 8:08am |
 |
@MarketCurrents $DBVT - DBV Tech up 17% premarket on Viaskin Peanut application in U.S. https://t.co/IvfV134oF8 August 8th 2019, 8:08am |
 |
@MarketChmln $DBVT gains in premarket trading. See the latest news. https://t.co/FJC8Uy2eGe https://t.co/sucudQgYNr August 8th 2019, 8:08am |
 |
@BankTheTrade $DBVT(9.14) up 1.50 on FDA peanut allergy application August 8th 2019, 6:08am |
 |
@zoom530 $DBVT SHORT $10.61 with 2K shares. Just read the news. Good night everyone. ???????????? https://t.co/2r1oVglq9d August 8th 2019, 5:08am |
 |
@portefeuillefun RT @biotechradar_eu: DBV Technologies $DBV $DBVT Submits Biologics License Application to U.S. Food and Drug Administration for Viaskin Pea… August 7th 2019, 5:08pm |
 |
@biotechradar_eu DBV Technologies $DBV $DBVT Submits Biologics License Application to U.S. Food and Drug Administration for Viaskin… https://t.co/o0V3xLhPUE August 7th 2019, 4:08pm |
 |
@Stock_News_Now $DBVT: New SEC Filing for DBVT: Form 6-K (No. 0001193125-19-215368): https://t.co/pb9EmYzpq2 August 7th 2019, 4:08pm |
 |
@TranscriptDaily DBV TECHNOLOGIE/S $DBVT Forecasted to Earn FY2023 Earnings of $1.55 Per Share https://t.co/JsEp7rIJM2 August 7th 2019, 6:08am |
|
@Gambiste1 RT @TradeFlags: TD BUY $DBVT at 8.95, Supp 8.70 Resis 10.10 R16 HiLo 24% T1Y 20 buy 2.3 fwdPE -2.0 DIV N/A #DBV Techno #stocks #trading #f… August 7th 2019, 4:08am |
 |
@TradeFlags TD BUY $DBVT at 8.95, Supp 8.70 Resis 10.10 R16 HiLo 24% T1Y 20 buy 2.3 fwdPE -2.0 DIV N/A #DBV Techno #stocks… https://t.co/ei6li5B5X0 August 7th 2019, 12:08am |
 |
@dailypoliticaln DBV TECHNOLOGIE/S $DBVT Stock Rating Lowered by Zacks Investment Research https://t.co/zl1lqjIvYE August 6th 2019, 10:08pm |
|
@macondailynews DBV TECHNOLOGIE/S $DBVT Receives $12.91 Average Price Target from Analysts https://t.co/uIj3yaxNyU August 5th 2019, 1:08pm |
|
@TheMarketsDaily DBV TECHNOLOGIE/S $DBVT Receives $12.91 Consensus Target Price from Analysts https://t.co/I6zBZiAhtc August 5th 2019, 1:08pm |
|
@TranscriptDaily ValuEngine Upgrades DBV TECHNOLOGIE/S $DBVT to Buy https://t.co/h5FPAm5HAT August 5th 2019, 11:08am |
 |
@WeekHerald ValuEngine Upgrades DBV TECHNOLOGIE/S $DBVT to Buy https://t.co/wxZDX52YIc August 5th 2019, 11:08am |
 |
@AmericanBanking Jefferies Financial Group Weighs in on DBV TECHNOLOGIE/S’s FY2023 Earnings $DBVT https://t.co/Itddg9jH0s #stocks August 5th 2019, 5:08am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.